2023
DOI: 10.3390/pathogens12050674
|View full text |Cite
|
Sign up to set email alerts
|

Recurrent Loss of Macrodomain Activity in Host Immunity and Viral Proteins

Abstract: Protein post-translational modifications (PTMs) are an important battleground in the evolutionary arms races that are waged between the host innate immune system and viruses. One such PTM, ADP-ribosylation, has recently emerged as an important mediator of host antiviral immunity. Important for the host–virus conflict over this PTM is the addition of ADP-ribose by PARP proteins and removal of ADP-ribose by macrodomain-containing proteins. Interestingly, several host proteins, known as macroPARPs, contain macrod… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
22
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(25 citation statements)
references
References 64 publications
3
22
0
Order By: Relevance
“…Its ART domain has an HYL (hydrophobic residue-tyrosine-leucine) domain as part of the catalytic triad, which restricts its ART activity to MARylation (28,29). PARP14 also has 3 tandem macrodomains (MD), of which MD1 has ADP-ribosylhydrolase (ARH) activity against MARylated protein and nucleic acid substrates, making it a rare enzyme that both adds and reverses the same post-translational modification (11,12). PARP14 also has a WWE domain that can bind to ADP-ribose subunits (30), several KH domains that facilitate protein and nucleic acid binding, and several RNA recognition motifs (RRMs) (10).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Its ART domain has an HYL (hydrophobic residue-tyrosine-leucine) domain as part of the catalytic triad, which restricts its ART activity to MARylation (28,29). PARP14 also has 3 tandem macrodomains (MD), of which MD1 has ADP-ribosylhydrolase (ARH) activity against MARylated protein and nucleic acid substrates, making it a rare enzyme that both adds and reverses the same post-translational modification (11,12). PARP14 also has a WWE domain that can bind to ADP-ribose subunits (30), several KH domains that facilitate protein and nucleic acid binding, and several RNA recognition motifs (RRMs) (10).…”
Section: Discussionmentioning
confidence: 99%
“…RNA was isolated from cells at 12 hpi and IFNβ mRNA was quantified by qPCR using ΔCt method. D) Parp14+/+ cells were infected with WT and N1347A at an MOI of 0.1 and then treated at 1 hpi with DMSO or increasing concentrations of PARP14 inhibitor (PARP14i) (3,11,33, 99 and 297nM). RNA was isolated from cells at 12 hpi and IFNβ mRNA levels were quantified using qPCR using ΔCt method.…”
Section: Quantification From Imagesmentioning
confidence: 99%
See 1 more Smart Citation
“…While the oocyst counts were increased after knockdown of either macro domain or peritrophin-44, only silencing of the peritrophin-44-like protein gene had a statistically significant effect on infection prevalence. Macro domain-containing proteins (ASTEI09413) are not well characterized in insects [ 56 , 57 ]; therefore, an association with the Wolbachia -induced anti- Plasmodium defense could be an interesting new field to explore. Similarly, little information is available about the peritrophin-44-like gene in insect–parasite interactions.…”
Section: Discussionmentioning
confidence: 99%
“…The subfamily of macrodomain containing PARP enzymes (PARP9, PARP14 and PARP15) was originally identified as B-aggressive lymphoma (BAL) proteins 1-3 [11]. PARP9 and PARP14 contain a macrodomain with ADP-ribosyl glycohydrolase activity [12][13][14] as well as one and two ADP-ribosyl binding macrodomains, respectively [15][16][17]. PARP15, the third member of the subfamily, originated by partial duplication of the structurally more complex PARP14 early during mammalian evolution.…”
Section: Introductionmentioning
confidence: 99%